Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657993 · ClinicalTrials.gov registry record · NA
Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence
A NA study of Breast Neoplasms and Musculoskeletal Pain, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
- 1
- Study location
NCT02657993: Completed NA study of Breast Neoplasms and Musculoskeletal Pain, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02657993 is a NA study of Breast Neoplasms and Musculoskeletal Pain that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 191 participants, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657993, a NA study of Breast Neoplasms and Musculoskeletal Pain, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether hypnosis is efficacious in reducing musculoskeletal pain in breast cancer survivors taking aromatase inhibitors, and by doing so, whether hypnosis can help survivors to be more adherent to their medication regimen.
Primary Outcome
The Brief Pain Inventory-Short Form (BPI-SF) is a self-report questionnaire assessing pain.
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Hypnosis
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
What the finished NCT02657993 record still lists
NCT02657993 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT02657993 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02657993 about?
NCT02657993 is a clinical study titled "Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence". The purpose of this study is to determine whether hypnosis is efficacious in reducing musculoskeletal pain in breast cancer survivors taking aromatase inhibitors, and by doing so, whether hypnosis can help survivors to be more adherent to their medication regimen.
What is the current status of trial NCT02657993?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2016-03. Estimated completion is 2021-03-18.
What conditions does trial NCT02657993 study?
This clinical trial studies the following conditions: Breast Neoplasms, Musculoskeletal Pain.
What interventions are being tested in trial NCT02657993?
The interventions under investigation include: Attention Control (BEHAVIORAL), Hypnosis (BEHAVIORAL).
Who is sponsoring clinical trial NCT02657993?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02657993 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02657993's enrollment target sits among peer trials
191 41st of 97 higher than 57 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Breast Cancer, Reasoning, and Activity Intervention
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RECRUITING · NA
-
Dissemination of BREASTChoice AIM1-B
RECRUITING · NA
-
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
ACTIVE NOT RECRUITING · NA
-
Lifestyle, Exercise, and Nutrition Study Early After Diagnosis
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia